James Emmett Young

Insider Reports History

Entity
Individual
Location
6272 W 91 St Ave, Westminster, CO
Signature
/s/ James Emmett Young
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Emmett Young:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TriSalus Life Sciences, Inc. Chief Financial Officer Common Stock 36.5K $206K $5.65 Feb 18, 2025 Direct
TriSalus Life Sciences, Inc. Chief Financial Officer Common Stock 30K $170K $5.65 Feb 18, 2025 By Kathleen A. Young Living Trust
TriSalus Life Sciences, Inc. Chief Financial Officer Employee Stock Option (right to buy) 75K Jan 27, 2025 Direct

Insider Reports Filed by James Emmett Young

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TLSI TriSalus Life Sciences, Inc. Feb 18, 2025 1 $0 4 Feb 19, 2025 Chief Financial Officer
TLSI TriSalus Life Sciences, Inc. Feb 5, 2025 1 $33.9K 4 Feb 6, 2025 Chief Financial Officer
TLSI TriSalus Life Sciences, Inc. Jan 27, 2025 3 $130K 4 Jan 29, 2025 Chief Financial Officer
TLSI TriSalus Life Sciences, Inc. Jan 6, 2025 0 $0 3 Jan 15, 2025 Chief Financial Officer